GLIMEPIRIDE; ROSIGLITAZONE MALEATE - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for glimepiride; rosiglitazone maleate and what is the scope of freedom to operate?
Glimepiride; rosiglitazone maleate
is the generic ingredient in two branded drugs marketed by Sb Pharmco and Teva Pharms Usa, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.Summary for GLIMEPIRIDE; ROSIGLITAZONE MALEATE
US Patents: | 0 |
Tradenames: | 2 |
Applicants: | 2 |
NDAs: | 2 |
Clinical Trials: | 1 |
DailyMed Link: | GLIMEPIRIDE; ROSIGLITAZONE MALEATE at DailyMed |
Recent Clinical Trials for GLIMEPIRIDE; ROSIGLITAZONE MALEATE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
GlaxoSmithKline | Phase 3 |
Canadian Heart Research Centre | Phase 3 |
Anatomical Therapeutic Chemical (ATC) Classes for GLIMEPIRIDE; ROSIGLITAZONE MALEATE
Paragraph IV (Patent) Challenges for GLIMEPIRIDE; ROSIGLITAZONE MALEATE
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
AVANDARYL | Tablets | glimepiride; rosiglitazone maleate | 8 mg/2 mg 8 mg/4 mg | 021700 | 1 | 2008-05-30 |
AVANDARYL | Tablets | glimepiride; rosiglitazone maleate | 1 mg/4 mg 2 mg/4 mg 4 mg/4 mg | 021700 | 1 | 2006-12-22 |